NVZMF News and Press, Novonesis AS - Class B From 02/21/25

2025-02-21 04:35:00 ET Summary The portfolio generated strong absolute returns in Q4 and 2024, and it outperformed the MSCI AC World Small Mid Index over each period. Q4 performance was driven by strong security selection, where portfolio holdings outperformed in 9 of the 10 secto...

2025-02-16 21:25:00 ET Summary The MSCI World Net Index climbed 18.7% for the year, marking its second consecutive annual gain above 15%, and capping a remarkable two-year run with a 47% total return. Mar Vista’s Global Quality strategy returned -3.31% net-of-fees in the fo...

Novonesis has reached an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, in exchange for a total cash consideration of EUR 1.5 billion. After more than 25 years of successful collaboration, a strategic repositioning at dsm...

2025-02-07 05:32:40 ET Summary Givaudan's fiscal year 2024 results were strong, with 12.3% like-for-like sales growth and a 22.1% increase in net income, despite currency headwinds. The company maintains a robust competitive moat through heavy R&D investment, a strong patent p...

2025-02-06 00:20:58 ET Summary Novonesis, formed from Novozymes and Christian Hansen, is a strong business with stable margins and high ROIC, but recent growth rates have declined. Despite solid Q3/24 results, NVZMF's long-term growth has slowed, though management and analysts exp...